18.81
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
11.43%
166.03
|
149.00 | 172.91 | 154.88 | 165.02 |
| Cost Of Revenue |
8.81%
52.98
|
48.70 | 47.82 | 49.44 | 54.07 |
| Gross Profit |
12.70%
113.05
|
100.31 | 125.08 | 105.44 | 110.95 |
|
|
0.03%
132.59
|
132.55 | 94.96 | 144.77 | 160.79 |
| Benefits Costs and Expenses |
2.27%
181.22
|
177.21 | 135.91 | 188.39 | 213.40 |
| Costs And Expenses |
2.27%
181.22
|
177.21 | 135.91 | 188.39 | 213.40 |
| Operating Income/Loss |
39.39%
-19.54
|
-32.24 | 30.13 | -39.33 | -49.84 |
| Nonoperating Income/Loss |
7.70%
4.348
|
4.037 | 6.871 | 5.822 | 1.459 |
| Income/Loss From Continuing Operations Before Tax |
46.13%
-15.19
|
-28.20 | 37.00 | -33.51 | -48.38 |
| Income Tax Expense/Benefit |
244.47%
1.059
|
-0.733 | 2.459 | 0.852 | 0.648 |
| Income/Loss From Continuing Operations After Tax |
40.84%
-16.25
|
-27.47 | 34.54 | -34.36 | -49.03 |
|
|
40.84%
-16.25
|
-27.47 | 34.54 | -34.36 | -49.03 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.37%
0.7847
|
125.50 | 123.76 | 122.61 | 0.3844 |
| Diluted Average Shares |
99.37%
0.7847
|
125.50 | 124.51 | 122.61 | 0.3844 |
| Basic Earnings Per Share |
40.91%
-0.13
|
-0.22 | 0.28 | -0.28 | -0.41 |
| Diluted Earnings Per Share |
40.91%
-0.13
|
-0.22 | 0.28 | -0.28 | -0.41 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):